Introduction {#S1}
============

The Rid/YER057c/UK114 protein superfamily (COG0251) is broadly conserved throughout all domains of life ([@B34]; [@B38]; [@B36], [@B37]; [@B9]; [@B44]; [@B10]). Based on phylogenetic analysis, the superfamily was divided into eight subfamilies; RidA, which includes homologs of the archetypical protein from *Salmonella enterica*, and Rid1-7, which are not well understood ([@B44]). Prokaryotic genomes can encode several members of the Rid1-7 subfamilies while also encoding one or more RidA proteins. In many genomes, the RidA homologs are not annotated with the ascribed biochemical function for these proteins. The RidA, [r]{.ul} eactive [i]{.ul} ntermediate [d]{.ul} eaminase [A]{.ul}, of *S. enterica* was found to be an enamine deaminase, and multiple homologs from the three domains of life have similar activity ([@B35]; [@B36]; [@B44]; [@B10]; [@B13]). In some organisms, a cellular role for RidA involves quenching the reactive metabolite 2-aminoacrylate (2AA) to prevent damage to specific pyridoxal 5′-phosphate (PLP)-dependent enzymes ([@B52]; [@B6]; [@B18]; [@B17]; [@B37]; [@B14], [@B11]; [@B44]; [@B30]). RidA homologs have a similar role in at least *Escherichia coli*, *Pseudomonas aeruginosa*, and *Saccharomyces cerevisiae*, although the phenotypic consequences of a *ridA* mutation depends on the specific metabolic network architecture of the organism ([@B4]; [@B13]; [@B30]). Enzyme damage resulting from accumulated 2AA can impact growth, motility, biofilm formation, iron homeostasis, and potentially virulence.

*Campylobacter jejuni* NCTC 11168, a prominent diarrheal pathogen, encodes two members of the Rid superfamily, a RidA homolog (Cj1388*)*, and a protein from the Rid2 subfamily (Cj0327). Data presented herein confirmed Cj1388 is a RidA protein and for clarity this locus is designated *~cj~ridA* throughout. Previous data suggested that *C. jejuni* Cj1388 (~Cj~RidA) plays a role in flagella-flagella interactions, possibly through regulation of flagellar glycan modification ([@B49]). Additionally, ~Cj~RidA has been highlighted in several global -omics studies in *C. jejuni* strains 11168 and 81176 (strain specific gene designation *cj1388* or *cj1390*, respectively) ([@B60]; [@B48]; [@B54]; [@B7]; [@B16]; [@B22]; [@B27]). These data sets suggest ~Cj~RidA could play a direct or indirect role in virulence, antibiotic resistance, acid adaptation, growth with bile salts, and hydrogen peroxide and oxygen stress. Finally, *~cj~ridA* is a member of the HeuR ([He]{.ul} me [u]{.ul} tilization [r]{.ul} egulator) regulon ([@B49]; [@B33]). HeuR is a PAS-domain containing regulator, and thought to be regulated in response to changing environmental cues ([@B49]; [@B33]). In other *Campylobacter* spp. including *C. coli*, *C. upsaliensis*, and *C. lari*, there is a co-occurrence of *heuR* and *~cj~ridA* in the genome, suggesting *~cj~ridA* may be regulated in response to differing environmental conditions in these organisms.

The ~Cj~RidA has been consistently misannotated as an endoribonuclease in *C. jejuni* studies, obscuring its likely connection to PLP-dependent enzymes and metabolism. In *S. enterica*, RidA catalyzes the hydrolysis of the 2AA intermediate formed by several PLP-dependent enzymes ([@B36]; [@B14], [@B11]). In the absence of RidA, free 2AA accumulates and can covalently inactivate certain PLP-dependent enzymes such as serine hydroxymethyltransferase (SHMT) (GlyA; EC 2.1.2.1), alanine racemases (Alr/DadX; EC 5.1.1.1), and transaminase B (IlvE; EC 2.6.1.42), leading to defects in one-carbon unit metabolism, cell-wall synthesis, and isoleucine biosynthesis, respectively ([@B52]; [@B17]; [@B12]). The activity of the enzymes targeted by 2AA can be decreased by 30--50% in strains lacking RidA ([@B35]; [@B12], [@B13]; [@B4]; [@B30]). To date, the diverse phenotypes of organisms lacking RidA suggest that there are additional and unknown targets of 2AA, possibly extending beyond PLP-dependent enzymes.

In at least *S. enterica*, *E. coli*, *P. aeruginosa*, *S. cerevisiae*, and *Arabidopsis thaliana*, a biosynthetic threonine/serine dehydratase (IlvA), acting on serine is the main source of 2AA in *ridA* mutants ([@B36]; [@B45]; [@B3]; [@B13]; [@B30]). In each of these organisms, IlvA has a regulatory domain and is allosterically inhibited by isoleucine ([@B19]; [@B52]). As a consequence, the presence of isoleucine eliminated generation of 2AA and suppressed the phenotypes of a *ridA* mutant. The specific targets of 2AA that result in detectable defects vary in different organisms. In *S. enterica*, 2AA accumulation causes a growth defect reversed by exogenous glycine; in *E. coli* 2AA accumulation-induced growth inhibition was reversed by exogenous aspartate, or purines; in *P. aeruginosa*, 2AA accumulation is detrimental to growth and partially reversed by exogenous proline and polyamines; and in *S. cerevisiae* mitochondrial accumulation of 2AA leads to loss of mitochondrial DNA and reduced heme biosynthesis ([@B17]; [@B12], [@B13]; [@B4]; [@B30]) (Whitaker and Downs, unpublished). The diverse effects of 2AA emphasize the complexity of the metabolic network and our limited understanding of the integration between biochemical pathways.

This study was initiated to understand the physiological role of ~Cj~RidA (Cj1388) in *C. jejuni* 11168. Although the levels of *~cj~ridA* were noted in multiple global studies, this gene was peripheral in those studies, and in many cases the results were not verified nor was the effect determined to be direct or indirect. The data herein suggest a role for ~Cj~RidA in flagellar biosynthesis, structure, glycosylation, and/or function. Further, we confirmed that ~Cj~RidA and the Rid2 subfamily member Cj0327, have enamine deaminase activity *in vivo* and *in vitro*. This work extends the list of organisms known to encode functional enamine deaminases of the Rid family.

Results {#S2}
=======

*Cj1388* and *Cj0327* Deaminate 2-Aminoacrylate *in viv*o {#S2.SS1}
---------------------------------------------------------

A *S. enterica ridA* mutant fails to grow on minimal medium with serine due to the accumulation of 2AA that is generated by the biosynthetic serine/threonine dehydratase encoded by *ilvA* (EC 4.3.1.19) ([@B52]; [@B37]). A *S. enterica ridA* mutant was transformed with pBAD24 constructs harboring a gene encoding Rid proteins from *C. jejuni* (*~cj~1388*/*~cj~ridA* or *cj0327*), the *S. enterica ridA* (*~se~ridA*) under the control of an arabinose promoter, or an empty vector control. Growth was monitored in minimal glucose medium with 5 mM serine and the data are shown in [Figure 1](#F1){ref-type="fig"}. Plasmids carrying either *~cj~ridA* (pDM1577) or *~se~ridA* (pDM1439) restored full growth to the *S. enterica ridA* mutant without inducing expression of the plasmid encoded genes. In contrast, *cj0327* (pDM1588) partially restored growth, and only when its expression was induced with arabinose.

![*~cj~ridA* complements a *Salmonella enterica ridA* mutant. A *S. enterica ridA* mutant with one of four plasmids was grown in a 96-well plate at 37°C shaking in minimal glucose (11 mM) medium with: **(A)** serine (5 mM), **(B)** serine and arabinose (0.2%), or **(C)** serine, arabinose and isoleucine (1 mM). The *S. enterica* strain carried plasmids expressing *S. enterica ridA* (filled circles), *C. jejuni ridA* (*~cj~ridA*, open squares), *C. jejuni rid*2 (*cj0327*, closed triangles), or empty vector (open triangles).](fmicb-10-02058-g001){#F1}

The inability of Cj0327, a Rid2 subfamily member, to fully complement the *S. enterica ridA* mutant was consistent with the results obtained for proteins annotated as Rid1-3 from *P. aeruginosa*, *Yersinia pestis*, *E. coli*, *Acinetobacter baylyi*, and *Pseudomonas syringae* ([@B28]; [@B30]) (Irons et al., unpublished). The partial complementation by Cj0327 and other proteins from the Rid1, 2, and 3 subfamilies suggests that these proteins may deaminate primarily non-2AA enamines *in vivo*. The specific physiological role of Cj0327 was not pursued further here.

*Cj1388* and *Cj0327* Have Deaminase Activity *in vitr*o {#S2.SS2}
--------------------------------------------------------

L-amino acid oxidase (LOX or LAAO)-based assays were used to assess the ability of purified Cj1388 and Cj0327 to deaminate imines *in vitro* ([@B25]; [@B45]; [@B44]; [@B28]; [@B8]). 2-aminobutyrate was provided as substrate, resulting in the LOX-dependent formation of 2-iminobutyrate. This imine reacts with semicarbazide to produce a semicarbazone which is monitored at 248 nm. Rid proteins can compete for the imine, converting it to the ketoacid, 2-ketobutyrate, similar to a reaction RidA catalyzes *in vivo*. Thus in this assay, the rate of semicarbazone formation is inversely proportional to Rid activity. The rate of semicarbazone formation (μM, min^--1^) with the addition of Cj1388 (~Cj~RidA) or Cj0327 is shown in [Figure 2](#F2){ref-type="fig"}. Consistent with the *in vivo* complementation data in an *S. enterica ridA* mutant, ~Cj~RidA has greater deaminase activity than Cj0327. When the Rid proteins are provided at higher concentrations (i.e., 10 μM), semicarbazone formation is reduced to the same extent by each protein, consistent with a saturating concentration of enzyme.

![~Cj~RidA and Cj0327 are imine deaminases *in vitro*. Each reaction mixture contained potassium pyrophosphate (50 mM, pH 8.7), neutralized semicarbazide (10 mM), bovine liver catalase (1 μg), and L-amino acid oxidase (0.5 μg) with or without the addition of ~Cj~RidA or Cj0327. 2-aminobutyrate (0.5 mM) was added to start the reaction and absorbance at 248 nm was monitored for 10 min. The graph shows the absorbance over time for reactions without ~Cj~RidA (circles) or with ~Cj~RidA at a final concentration of 1.0 μM (triangles). Error bars represent standard deviation of the mean determined from three technical triplicates by GraphPad Prism 7.0c. The molar extinction coefficient for semicarbazone (ε = 10,300 M^--1^ cm^--1^) was used to calculate the rate of semicarbazone formation (μM, min-1) in reactions without Rid proteins and with ~Cj~RidA and Cj0327 in concentrations of 0.1, 1.0, and 10 μM. Standard deviation of the mean was determined from three technical triplicates by GraphPad Prism 7.0c.](fmicb-10-02058-g002){#F2}

*Campylobacter jejuni* Mutants Lacking *~cj~ridA* Have a Motility Defect {#S2.SS3}
------------------------------------------------------------------------

Data from several bacterial species suggested RidA is involved in flagellar biosynthesis and/or motility ([@B49]; [@B3]; [@B30]). A variant of *C. jejuni* 11168 lacking *~cj~ridA* was generated and assessed for swimming motility on Mueller Hinton (MH) medium with 0.4% agar and 0.01% Triphenyltetrazolium Chloride (TTC). The data ([Figure 3](#F3){ref-type="fig"}) showed that the *~cj~ridA* mutant had significantly decreased motility when compared to wild type over the course of 72 h. A non-motile, aflagellate *pseC* mutant was used as a control to determine the spread of the inoculum that was due to diffusion. The motility data in [Figure 3](#F3){ref-type="fig"} is representative of experiments that were performed more than ten times on ten different days and included three independently constructed *~cj~ridA* mutants. Although there was day-to-day variation in the absolute motility measured, the difference between the mutant and control strains remained consistent at ∼2-fold. Motility was not affected by a lesion in the gene encoding the Rid2 subfamily member (*cj0327*) in either a wild-type background or the *~cj~ridA* mutant, (data not shown). This result supported the conclusion that the ~Cj~RidA and Cj0327 proteins are not physiologically redundant in *C. jejuni*, consistent with what has been found in other organisms. Addition of isoleucine (1 mM) to the motility agar did not affect the motility defect of the *~cj~ridA* mutant (data not shown), and motility was restored to wild-type levels when *~cj~ridA* was inserted into pseudogene *cj0046* and expressed with its native promoter ([Figure 4](#F4){ref-type="fig"}).

![*Campylobacter jejuni ridA* mutants have a significant defect in motility. Swimming motility was determined for *C. jejuni* wild type (black) and a *~cj~ridA* mutant (gray). Ten microliter of cell suspension was inoculated in the center of MH agar (0.4%) plate that was incubated up to 72 h in microaerophilic conditions. Motility was defined as swimming-dependent spread by subtracting the diameter of inoculum diffusion from the motility zone and dividing it by two. Error bars represent the standard errors of the mean of three technical triplicates, for wild type, and two biological replicates in technical triplicate for the *~cj~ridA* mutant. Significance was determined between wild type and*~cj~ridA* mutant for each time period and an asterisk denotes statistically significant (*P* \< 0.005) variation between mutants, as determined by an unpaired Student *t* test performed with GraphPad Prism software, v7.0C.](fmicb-10-02058-g003){#F3}

![Motility of *Campylobacter jejuni ridA* mutants differs with media composition. Growth (not shown) and motility were improved by complex undefined-media. Motility of the *C. jejuni* wild type (black), *~cj~ridA* mutant (gray), or the chromosomally complemented *~cj~ridA* mutant (*~cj~0046*: *~cj~ridA*-kan) (striped) was improved in Brucella or BHI as compared to MH motility agar (0.4%). Ten microliter of cell suspension was inoculated in the center of each agar (0.4%) plate that was incubated up for 36 h in microaerophilic conditions. Motility was defined as swimming-dependent spread by subtracting the diameter of inoculum diffusion from the motility zone and dividing it by two. Error bars represent the standard errors of the mean of three technical triplicates of wild-type and three biological replicates of *~cj~ridA* and *~cj~0046*:*~cj~ridA*-kan. Significance was determined between wild type and*~cj~ridA* mutant for each time period and an asterisk denotes statistically significant (*P* \< 0.02) variation between mutants, as determined by an unpaired Student *t* test performed with GraphPad Prism software, v7.0C.](fmicb-10-02058-g004){#F4}

A previous study reported *~cj~1388* mutants had increased motility compared to wild-type in Brucella motility agar, a rich undefined medium ([@B49]). Motility was assessed in Brucella, brain heart infusion (BHI), and MH motility agar for two mutants and wild type and the data are in [Figure 4](#F4){ref-type="fig"}. Both Brucella and BHI media support increased mobility (and growth) of both mutants and wild type. Similar to what was previously reported, *~cj~ridA* mutant motility was 1.1-fold and 1.4-fold higher than wild-type in BHI and Brucella motility media, respectively. Significantly, the *~cj~ridA* mutant displayed a motility defect only on MH medium. The restoration of motility on the two complex media is consistent with regulation of metabolic flux in *~cj~ridA* mutants limiting the production of, and/or damage by, the reactive enamine substrate of the ~Cj~RidA protein. For instance, in *S. enterica* and *P. aeruginosa ridA* mutant motility defects only arise when minimal defined media is used and the defects are eliminated by the addition of isoleucine which prevents 2AA formation. Given the complexity of metabolic systems and regulation, minimal defined media will be used in future studies to determine the impact of *~cj~ridA* mutations motility.

~Cj~RidA Is Required for Full Infection and/or Lysis by Phage NCTC 12673 {#S2.SS4}
------------------------------------------------------------------------

The *C. jejuni* lytic phage, NCTC 12673 has decreased plaquing efficiency on aflagellate mutants ([@B31]) and fails to form plaques on *pseC* mutants ([@B50]). Plaque formation by NCTC 12673 was assessed with serially diluted aliquots of a phage lysate spotted on 0.6% agar overlays seeded with the indicated mutant or wild type. The efficiency of plating was tested on wild-type *C. jejuni*, a *~cj~ridA* mutant ([Figure 5](#F5){ref-type="fig"}) and a *pseC* mutant. As expected, no plaques were visible on the *pseC* mutant, which lacks the ability to synthesize pseudaminic acid, the major glycan modification of FlaA and FlaB subunits of the flagellum, and is therefore aflagellate ([@B32]; [@B50]). When plated on wild-type *C. jejuni*, the phage titer was 1 × 10^7^ PFU/ml. When the same lysate was plated on a *~cj~ridA* mutant, the titer was 2 × 10^6^. This approximately 5-fold decrease in plating efficiency compared to the parental strain was consistent with the hypothesis that the *~cj~ridA* mutant had a defect in flagellar biosynthesis and/or function.

![*~cj~ridA* mutants support reduced plaque formation of phage NCTC 12673. A phage lysate was titered on *C. jejuni* wild type (black), a *~cj~ridA* mutant (gray) and *pseC* mutant (plaquing efficiency of zero). Serial dilutions of the lysate were spotted on a NZCYM 0.6% agar overlay seeded with the appropriate bacterial mutant. After 1 day, plaque forming units (PFU/mL lysate) were determined with three technical triplicates of wild type, and two biological replicates in technical duplicate for the *~cj~ridA* mutant. Number of plaques on wild type was defined as an efficiency of 1.](fmicb-10-02058-g005){#F5}

*~cj~ridA* Mutants Have a Defect in Autoagglutination {#S2.SS5}
-----------------------------------------------------

The decreased motility and sensitivity to phage NCTC 12673 suggested a flagellar defect in the *~cj~ridA* mutants. In both cases, the *~cj~ridA* mutant phenotype fell between that of the wild type and the *pseC* mutant, which completely lacks flagella. Consistently, a hallmark of *ridA* mutants is the decreased, but not eliminated activity of the enzymes targeted by 2AA causing phenotypes that are less severe than complete lesions of the relevant enzymes. Changes in autoagglutination (AAG) can also indicate a change in flagella, specifically in flagellar glycan decoration, which correlates with a reduction in virulence ([@B24]; [@B29]; [@B42]). Reuter et al. reported that a *cj1388* (*~cj~ridA*) mutant had a slower rate of AAG compared to wild-type *C. jejuni* 11168, in medium supplemented with Tween-20 (0.002%) ([@B49]). AAG was determined in our hands for wild type and *~cj~ridA* mutant after suspension in several different media. Cells were harvested from MH agar plates and suspended in MH or PBS as appropriate. The cell suspension was adjusted to an OD~600~ of 1.0 in 5 mL of: (i) MH, (ii) MH with 0.002% Tween-20, or (iii) PBS. Consistent with previous observations, the *~cj~ridA* mutant had a significant and reproducible decrease in AAG compared to wild type in MH supplemented with 0.002% Tween-20, reflected by more cells remaining in suspension ([Figure 6](#F6){ref-type="fig"}). Each mutant was tested in triplicate. To ensure that any observed difference in phenotype was due to specific mutation, three separate clones for each mutant were tested separately and then the data were combined. The defect of a *~cj~ridA* mutant appeared to reflect a slower rate of AAG, since the defect was significant after a 24-h incubation, but by 48 h the mutants were not significantly different than wild type. In our hands, other media used in reported AAG protocols (PBS or MH alone) failed to result in visible differences between the mutant and wild type. As expected, a *pseC* mutant showed almost complete cessation of AAG, thus another phenotype of the *~cj~ridA* mutant fell between that of a wild type and the *pseC* mutant ([Figure 6](#F6){ref-type="fig"}). The decreased rate of autoagglutination in a *~cj~ridA* mutant supported the emerging model that ~Cj~RidA directly or indirectly affects flagellar regulation, biogenesis, glycosylation, or structure.

![*Campylobacter jejuni ridA* mutants have an autoagglutination defect during the first 24 h. Autoagglutination was measured using *C. jejuni* wild type (black), a *~cj~ridA* mutant (light gray) and a *pseC* mutant (white). % AAG represents the percentage of cells that autoagglutinated and settled in the bottom of the tube after 24 h, determined by the formula \[(OD~600i~--OD~600r~)/OD~600i~\] × 100. Error bars represent the standard errors of the mean of three technical triplicates, for wild type and *pseC* mutant, and two biological replicates in technical duplicate for *~cj~ridA* mutants. Significance was determined between each mutant and wild type. One asterisk denotes statistically significant (*P* \< 0.005) and two asterisks denote statistically significant (*P* \< 0.0005) variation between mutants, as determined by an unpaired Student *t* test performed with GraphPad Prism software, v7.0C.](fmicb-10-02058-g006){#F6}

Transmission Electron Microscopy Shows ~Cj~RidA Impacts Flagella {#S2.SS6}
----------------------------------------------------------------

Transmission electron microscopy (TEM) was performed on cells harvested from MH agar plates and suspended in PBS ([@B24]). Efforts to fix cells with glutaraldehyde and formaldehyde or paraformaldehyde and stain with uranyl acetate or phosphotungstic acid failed to yield clear images and thus the cells were imaged with no fixative or stain ([Figure 7B](#F7){ref-type="fig"}). The number of flagella were quantified using two independently constructed *~cj~ridA* mutants and a wild-type strain of *C. jejuni* ([Figure 7A](#F7){ref-type="fig"}). One hundred cells with two unobstructed poles from each mutant and the wild type were used for quantification. Of the one hundred wild-type cells observed, ∼ 60% had bipolar flagella, ∼20% had a single flagellum, and ∼20% had no visible flagellum. In contrast, of the 200 *~cj~ridA* mutant cells observed, 20% had bipolar flagella, \<40% had a single flagellum, \<40% had no flagella. Beyond the number, structural anomalies of the flagella were noted in the mutant cells that were not seen in the wild-type sample ([Figure 7B](#F7){ref-type="fig"}). First, there were "nub" structures on one or both poles of the bacterium (∼10% of mutant cells). Secondly, there were instances where flagella in the mutant were unusually long and apparently thinner than the wild type. Together these observations showed that the lack of ~Cj~RidA significantly impacted flagellar synthesis and or assembly. TEM images do not provide clarity on the specific flagellar defect caused by a *~cj~ridA* mutation. Regardless, the images, in combination with the phenotypic analysis above allowed the conclusion that ~Cj~RidA is important for the full formation of a functional flagella.

![TEM detects flagellar differences in *~cj~ridA* mutants. TEM was used to visualize the flagella of wild type and two *~cj~ridA* mutant*s* on multiple days. One hundred cells with clearly visible poles were assessed in each mutant or wild type. Pie charts in **(A)** represent the distribution of bipolar flagella (blue), a single polar flagellum (red) no flagellum (green) and truncated flagella (hatched). For wild type, *N* = 100, for *~cj~ridA*, *N* = 200 (with 100 from each of two independent mutants) and long and thin flagella (quantified as bipolar or single) were classified by number of flagellar filaments. Lower panels **(B1--B7)** show representative TEM images for cells with: **(B1)** bipolar flagella, wild type is represented: **(B2)** no flagellum, *~cj~ridA* mutant is represented; **(B3)** a single polar flagellum,*~cj~ridA* mutant is represented; **(B4)** truncated flagella, seen only in *~cj~ridA* mutants; and **(B5--B7)** long, potentially thin flagella, seen only in *~cj~ridA* mutant.](fmicb-10-02058-g007){#F7}

Cj0828 Is the Biosynthetic Serine/Threonine Dehydratase in *C. jejun*i {#S2.SS7}
----------------------------------------------------------------------

In five organisms previously characterized, the phenotypic effects of eliminating the RidA homolog were due to the accumulation of 2AA, generated by a PLP-dependent serine threonine dehydratase enzyme (EC 4.3.1.19). As a consequence, a hallmark of the paradigm thus far has been the suppression of all defects by exogenous isoleucine, which allosterically inhibits the dehydratase enzyme(s). Within this context, it was striking that phenotypes associated with a *~cj~ridA* mutation in *C. jejuni* were apparent in nutrient (MH) medium that contained abundant isoleucine. *C. jejuni* encodes a single gene annotated as a PLP-dependent serine/threonine dehydratase, (Cj0828, EC 4.3.1.19). Cj0828 shares 32% identity to *S. enterica* IlvA ([Figure 8](#F8){ref-type="fig"}) but it lacks the C-terminal domain that contains the allosteric site for inhibition by isoleucine ([@B19]; [@B5]). These data suggested that if *cj0828* encoded the legitimate biosynthetic threonine dehydratase, the presence of isoleucine would not prevent generation of 2AA by this enzyme. An insertion deletion was introduced into *cj0828* and growth was tested on a defined minimal medium (MCLMAN). In minimal medium, the *cj0828* mutant required isoleucine for full growth, indicating this gene product was the biosynthetic serine/threonine dehydratase *in vivo* (data not shown). To reflect this result, the gene was renamed *~cj~ilvA.* The identification of *~cj~ilvA* suggested three possible scenarios to explain the RidA paradigm in *C. jejuni*: 1) *~cj~ilvA* is constitutively expressed and thus generates 2AA even on nutrient medium, 2) there are other enzyme(s) in the cell that generate 2AA, or 3) 2AA is not responsible for the phenotypes of the *~cj~ridA* mutant. The latter would suggest there was another reactive metabolite produced in the cell that is quenched by ~Cj~RidA.

![*Campylobacter jejuni* Cj0828 is an IlvA homolog. *Salmonella enterica* IlvA and *Campylobacter jejuni* Cj0828 protein sequences share 32% identity. *Cj0828* (~cj~IlvA) lacks the C-terminal domain that contain the site of allosteric regulation by isoleucine.](fmicb-10-02058-g008){#F8}

*C. jejuni* Expands Features of the RidA Paradigm {#S2.SS8}
-------------------------------------------------

The contribution of ~Cj~IlvA to the phenotypes of a *~cj~ridA* mutant was tested by constructing a double mutant. A *~cj~ilvA* loss of function mutation was introduced into a ~cj~*ridA* mutant background and the resulting double mutant was assessed for motility. Motility assays were performed with the *~cj~ridA ~cj~ilvA* double mutant on MH with 0.4% agar ([Figure 9](#F9){ref-type="fig"}). The motility of the *~cj~ilvA* mutant was indistinguishable from the parental wild type. Similarly, the motility of the *~cj~ridA ~cj~ilvA* double mutant was no different than the single *~cj~ridA* mutant. Importantly, both mutants carrying a *~cj~ridA* mutation had a \>2-fold decrease in motility compared to their respective parental strain. These data showed that ~Cj~IlvA was not the source of sufficient 2AA to result in the phenotypes detected for the *~cj~ridA* mutant on MH motility agar. Thus, the source of the reactive enamine presumed to be responsible for the flagellar defects of the *~cj~ridA* mutants remains to be determined.

![A *~cj~ilvA* mutation does not eliminate the phenotype of a *~cj~ridA* mutant. Mutants were grown on BHI overnight. Then cells were scraped from agar surface, resuspended in 1 mL of PBS and the OD~600~ was set to 1.0. Then, 10 μL of cell suspension was used to inoculate the center of a MH 0.4% agar plate. After 48 h the diameter of motility was measured and the values adjusted to account for the swimming-independent spread of the inoculum, as determined by the non-motile *pseC* mutant. The wild-type parental strain (black) and the *ilvA*:cat mutant (gray) had no defect in motility. The *~cj~ridA* mutant (horizontal stripe) had a \>2-fold decrease in motility that was not restored in a*~cj~ridA ilvA* double mutant (vertical stripe). Error bars represent the standard errors of the mean of three technical triplicates, for wild type, and two biological replicates in technical triplicate for *~cj~ridA* and *~cj~ridA cj0828* mutants. Significance was determined between each mutant and wild type; asterisk denotes statistically significant (*P* \< 0.0001) variation between mutants, as determined by an unpaired Student *t* test performed with GraphPad Prism software, v7.0C.](fmicb-10-02058-g009){#F9}

Discussion {#S3}
==========

The data herein demonstrate that the gene designated *cj1388* in *Campylobacter jejuni* 11168 is a RidA with 2AA deaminase activity *in vivo*. *C. jejuni* is the first organism to date where the major phenotypic consequences of lacking RidA are not caused by the activity of a serine threonine dehydratase. Thus *C. jejuni* provides an opportunity to identify additional generators of reactive enamine(s) like 2AA, that can impact the physiology of different organisms in the absence of RidA. One of the two additional 2AA generators found in *S. enterica*, cysteine desulfhydrase (CdsH; EC 2.5.1.47), appears to be present in *C. jejuni* and additional work will determine if this enzyme has a role in generating the phenotypes of a *~cj~ridA* mutant.

Results presented herein, which used three independent *~cj~ridA* mutants, suggest *C. jejuni* 11168 lacking *ridA* has a defect in flagellar biosynthesis, regulation, or structure. *C. jejuni* mutants lacking *~cj~ridA* have defects in motility, AAG, and phage infectivity, all of which require or are enhanced by flagella ([@B23]; [@B21]; [@B32]). Motility is essential for *C. jejuni* to move through the viscous mucosal environment to colonize a human host, and protein glycosylation is essential for flagellar biosynthesis and function. Flagellum (FlaA and FlaB) subunits are modified by O-linked pseudaminic and legionaminic acids and their derivatives at up to 19 Ser/Thr sites before export and assembly of the flagellar apparatus ([@B55]; [@B40]; [@B51]; [@B39]; [@B15]). Importantly, thus far the only defined targets of accumulated 2AA are PLP-dependent enzymes. Given the importance of glycosylation of the flagellar subunits, it is possible that the UDP-4-amino-4,6-dideoxy-N-acetyl-ß--L-altrosamine transaminase (Cj1294/PseC; EC 2.6.1.92), a fold-type II PLP-dependent enzyme, could be a critical target of 2AA and thus be damaged in a *~cj~ridA* mutant.

Our favored model suggests that 2AA accumulates in a *~cj~ridA* mutant and damages PLP-dependent enzyme, PseC, leading to a decrease in pseudaminic acid modification on FlaA. Consistent with this model, changes in FlaA glycosylation affect AAG, motility, and virulence ([@B41]; [@B55]; [@B40]; [@B51]; [@B24]; [@B15]). Based on other examples, damage by 2AA is expected to reduce the activity of PseC 30--50% ([@B35]; [@B12], [@B13]; [@B4]; [@B30]). In this case, the phenotypes resulting from PseC damage could vary among the cell population and be similar to the range of phenotypes previously shown from *flaA* point mutations ([@B15]; [@B56]; [@B61]).

Materials and Methods {#S4}
=====================

Bacterial Strains, Plasmids and Media {#S4.SS1}
-------------------------------------

The strains, plasmids and primers used in this study are listed in [Tables 1](#T1){ref-type="table"}--[3](#T3){ref-type="table"} with their sources. *C. jejuni* human isolate NCTC 11168 ([@B47]) was used as the parental strain. Derivatives of *S. enterica* serovar Typhimurium LT2 (*S. enterica*) were used for *in vivo* complementation studies.

###### 

Strains used in this study.

  **Organism**                   **Mutant ID**   **Genotype**                  **Plasmid**                  **Source**
  ------------------------------ --------------- ----------------------------- ---------------------------- ---------------
  *Salmonella enterica*          DM14846         *ridA1*:Tn10(Tc)              pDM1439                      Downs lab
                                 DM14847         *ridA1*:Tn10(Tc)              pCV1 (Empty vector)          [@B57]
                                 DM16385         *ridA1*:Tn10(Tc)              pDM1577 (*cj1388*)           This study
                                 DM16513         *ridA1*:Tn10(Tc)              pDM1588 (*cj0327*)           This study
  *Escherichia coli*             DM16869         DH5a                          pCASO29 (*cj1388*:kan)       [@B49]
                                 DM16508         BL21AI                        pDM1589 (pET28b\_*cj0327*)   This study
                                 DM16383         BL21AI                        pDM1578 (pET28b\_*cj1388*)   This study
  *Campylobacter jejuni* 11168   DMC1            Wild type                     **--**                       [@B47]
                                 DMC2            *pseC*:kan                    **--**                       Szymanski Lab
                                 DMC3            *cjridA*:kan A                **--**                       This study
                                 DMC4            *cjridA*:kan B                **--**                       This study
                                 DMC5            *cjridA*:kan C                **--**                       This study
                                 DMC6            *cj0327*:cat A                **--**                       This study
                                 DMC7            *cj0327*:cat B                **--**                       This study
                                 DMC8            *cj0327*:cat C                **--**                       This study
                                 DMC9            *cjridA*:kan *cj0828*:cat A   **--**                       This study
                                 DMC10           *cjridA*:kan *cj0828*:cat B   **--**                       This study
                                 DMC11           *cjridA*:kan *cj0828*:cat C   **--**                       This study
                                 DMC12           *cj0046*:*cjridA*- cat A      **--**                       This study
                                 DMC13           *cj0046*:*cjridA*- cat B      **--**                       This study
                                 DMC14           *cj0046*:*cjridA*- cat C      **--**                       This study

###### 

Plasmids used in this study.

  **Plasmid**   **Description**                        **Source**
  ------------- -------------------------------------- ------------
  pCV1          BspQI modified pBAD24 vector           Downs Lab
  pDM1439       *Salmonella enterica ridA* pBAD24      Downs Lab
  pDM1577       *Campylobacter jejuni cj1388* pBAD24   This study
  pDM1588       *Campylobacter jejuni cj0327* pBAD24   This study
  pDM1589       BspQI modified pET28b\_*cj0327*        This study
  pDM1578       BspQI modified pET28b\_*cj1388*        This study
  pCASO29       Gene disruption plasmid *cj1388*:kan   [@B49]
                                                       

###### 

Primers used in this study.

  **Purpose**                                              **Primer name**                                          **Sequence**                    
  -------------------------------------------------------- -------------------------------------------------------- ------------------------------- -------------------------------------------
  Primers for pBAD24 cloning                               Complementation in *Salmonella enterica*                 cj1388 pBAD24 For               NNGCTCTTCNTTCATGTCAAACTATCCAAA
                                                                                                                    cj1388 pBAD24 Rev               NNGCTCTTCNTTATTATCCTTTTTGAGCGAT
                                                                                                                    cj0327 pBAD24 For               NNGCTCTTCNTTCATGATAAAGCGTTTTGA
                                                                                                                    cj0327 pBAD24 Rev               NNGCTCTTCNTTATTAATTCTCTCTTAGCTTT
  Primers for pET28b protein overexpression                Cj1388_pPET28b_Rev                                       NNGCTCTTCNGTGTCCTTTTTGAGCGAT    
                                                           Cj0327_pET28b_Rev                                        NNGCTCTTCNGTGATTCTCTCTTAGCTTT   
  Primers for *Campylobacter jejuni* deletion constructs   Check *cj1388*:kan                                       cj1388 Seq For                  GTTGTTTTTGTCCCTCATCCAT
                                                                                                                    cj1388 Seq Rev                  TAAAGAAAAAACAATACCTAGC
                                                           Construct *cj0828*:cat                                   P1 del cj0828                   TATTAAACTTCGGAATTTGCTATATTATAACACTTTTTTC
                                                                                                                    P2 del cj0828                   ATCCACTTTTCAATCTATATCTATTTTTCCTTTGTTTTAAA
                                                                                                                    P3 del cj0828                   CCCAGTTTGTCGCACTGATAATAACATATACGGCTTAAATA
                                                                                                                    P4 del cj0828                   CTTCAAAAACAACTTAATAAATTTTCCCATCCTTTTATCC
                                                           Check *cj0828*:cat                                       cj0828 Seq For                  TTTAAAACAAAGGAAAAATA
                                                                                                                    cj0828 Seq Rev                  TATTTAAGCCGTATATGTTA
                                                           Construct *cj0327*:cat                                   P1 del Cj0327                   AATTTCGGGTTTAAGTTGTA
                                                                                                                    P2 del Cj0327                   ATCCACTTTTCAATCTATATCTTTATCATGCATATTTTCCT
                                                                                                                    P3 del Cj0327                   CCCAGTTTGTCGCACTGATAAAATTAAAAATTCTCTCCTCC
                                                                                                                    P4 del Cj0327                   GGAGACGGTGCAGGTGCTGG
                                                           Check *cj0327*:cat                                       Cj0327 Seq For                  GAATTTCAAGGAAAATATGC
                                                                                                                    Cj0327 Seq Rev                  ACTTGGGGATCTGCGCTTTT
                                                           Construct *cj0046*:*cj1388*-cat chromosomal complement   P1 Up For Cj0046                GAAGATAATTCTTGGCATTT
                                                                                                                    P2 Up Rev Cj0046                TCCACTTTTCAATCTATATCGCAGTATTTGAAGGAGTAAC
                                                                                                                    P3 For Cat cassette             GTTACTCCTTCAAATACTGCGATATAGATTGAAAAGTGGA
                                                                                                                    P4 Rev Cat cassette             GCCTTTGGATAGTTTGACATGAATTCTCCTTATCAGTGCG
                                                                                                                    P5 Cj1388 For                   CGCACTGATAAGGAGAATTCATGTCAAACTATCCAAAGGC
                                                                                                                    P6 Cj1388 Rev                   TAAAACTCCCCTAGCATGTTTTATCCTTTTTGAGCGATGA
                                                                                                                    P7 Down For Cj0046              TCATCGCTCAAAAAGGATAAAACATGCTAGGGGAGTTTTA
                                                                                                                    P8 Down Rev Cj0046              TTAATAAAATCCTAAAATTTTCC
                                                           Amplify cat cassette                                     P5 del cj0828                   GATATAGATTGAAAAGTGGAT
                                                                                                                    P6 del cj0828                   TTATCAGTGCGACAAACTGGG

Derivatives of *C. jejuni* 11168 were grown on Mueller Hinton (MH, 21 g/liter), Brain heart infusion (BHI, 37 g/L), Brucella agar (28.1 g/L) or NZCYM (22 g/L) at 37°C under microaerobic conditions (85% N~2~, 10% CO~2~, 5% O~2~) ([@B2]). *S. enterica* and *E.* coli strains were grown in Difco Nutrient Broth (8 g/l) with NaCl (5 g/l) at 37°C. Minimal medium was NCE salts with MgSO~4~ ([@B58]), trace minerals ([@B1]), and 11 mM glucose. Additions, isoleucine (1 mM), and serine (5 mM) were added as indicated. Antibiotic concentrations were as follows; 150 μg/mL ampicillin or 50 μg/mL kanamycin were used for *S. enterica* and 15 μg/mL chloramphenicol or 30 μg/mL kanamycin were used for *C. jejuni*. When needed to induce expression of genes in relevant plasmids, L-arabinose was added (0.2%). Chemicals were purchased from MilliporeSigma (Sigma-Aldrich, St. Louis, MO).

Growth Quantification {#S4.SS2}
---------------------

Growth of *S. enterica* in liquid culture was assessed using a BioTek Elx808 microtiter plate reader following optical density at 650 nm at 37°C with slow shaking speed. Overnight cultures of *S. enterica* in biological triplicate were grown in rich medium at 37°C, pelleted and resuspended in an equal volume of sterile NaCl (8.5 g/L). The resulting cell suspension was used to inoculate growth medium (2% inoculum) and growth was monitored for 24 h. The resulting data were plotted using GraphPad Prism 7.0, generating curves in log10-format that display the mean of three replicates and standard deviation of the mean. Specific growth rates (μ) were calculated according to the following equation: ln(X/X~0~)/T, where X is OD~650~, X~0~ is the starting OD~650~ of the exponential growth period monitored, and T is time in hours.

Molecular Biology {#S4.SS3}
-----------------

A plasmid (pCASO29) with a deletion/kanamycin insertion construct in *cj1388* was used to construct a *~cj~ridA*:kan mutant (DMC3, DMC4, and DMC5) ([@B49]). A *pseC*:kan mutant was obtained from the Szymanski laboratory collection. Additional mutants were constructed using standard methods ([@B26]; [@B53]). Briefly, to generate an insertion/deletion in a gene of interest, homology both up- and down-stream to the gene of interest was joined to a drug resistance cassette by overlap extension PCR. PCR products were purified using Qiagen gel extraction kit (ID 28506). The natural competence of *C. jejuni* was exploited to transform the PCR product into cells grown on nutrient rich medium, BHI with 2% yeast extract. After 24 h growth, cells were streaked on selective medium and colonies formed after 3-5 days. Colonies were streaked for isolation and culture stocks were frozen in glycerol. Insertion deletions of relevant genes was confirmed by PCR. The complete protocol for Natural Transformation can be found on Protocols.io at <https://dx.doi.org/10.17504/protocols.io.magc2bw>.

Derivatives of plasmid pBAD24 and pET28b were created using a BspQI restriction cloning method as previously described by [@B20] with a modified vector that contained the BspQI site (pCV1) ([@B57]). *S. enterica* or *E. coli* competent cells were prepared and transformed using standard method. Transformants were recovered in nutrient broth, plated to selective medium at 37°C before isolating and confirming the plasmid structure.

For *pseC*:km mutant construction, *pseC* was amplified from 11168 using the *pseC*-F and *pseC*-R primers ([Table 3](#T3){ref-type="table"}). This insert was purified, digested with *Bam*HI and *Xho*I, inserted into PCRscript (Stratagene) digested with the same enzymes, and transformed into *E. coli* DH5α. The extracted plasmids were digested with *Xho*I and *Bam*HI to confirm insert presence and one plasmid subsequently digested with *Nco*I, purified, blunted and treated with alkaline phosphatase to prevent re-ligation. The *pseC* gene was interrupted by ligating a kanamycin resistance cassette (km). The mutant was confirmed using the *pseC*-F/mid KmR primer pair ([Table 3](#T3){ref-type="table"}) and sequenced.

Protein Production and Purification {#S4.SS4}
-----------------------------------

Proteins ~Cj~RidA and Cj0327 were purified from *E. coli* strain BL21AI harboring pET vector constructs. The polyhistidine-tagged proteins were purified by nickel-affinity chromatography as previously described ([@B35]). Overnight cultures in LB (10 mL) were used to inoculate flasks containing super broth (1.5 L) supplemented with kanamycin (50 μg/mL). Cultures were grown at 37°C with shaking until an OD~650~ between 0.7 and 1.0 was reached. Arabinose (0.2%) was added to induce T7 RNA polymerase for 18 h. Cells were harvested by centrifugation at 7,000 × *g* and the cell pellets were stored at −80°C until use. Binding buffer (50 mM potassium phosphate pH 7.5, 100 mM NaCl, 5 mM imidazole, and 10% glycerol) was added to thaw cells (2 mL per gram wet cell weight) along with lysozyme (1 mg/mL) and DNase (20 Units/mL), and the cells were lysed with a One Shot Cell Disruptor at 18,000 psi (Constant Systems). The lysate was clarified by centrifugation (40,000 × *g* for 45 minutes) and passed through a 0.45 μm syringe filter (Argos Technologies) prior to being loaded onto 5 mL HisTrap^TM^ HP column and purified using the manufacturer's protocol (GE Healthcare). Protein was eluted with a 0--100% gradient of elution buffer (50 mM potassium phosphate pH 7.5, 100 mM NaCl, 500 mM imidazole and 10% glycerol). The fractions were assessed for purity, pooled, and concentrated using a 7,000 molecular weight cut-off protein concentrator (Millipore). The protein preparations were dialyzed into storage buffer (50 mM potassium phosphate pH 7.5, 10% glycerol) using a PD-10 desalting column (GE Healthcare). Proteins were subjected to SDS/PAGE and purity was assessed using a Foto/Analyst FX (Fotodyne) imager and TotalLab Quant v11 densitometry software. Protein concentration was quantified using BCA Protein Assay (Thermo Scientific), and the samples were frozen in liquid nitrogen and stored at −80°C.

L-Amino Acid Oxidase Assays {#S4.SS5}
---------------------------

The LOX-based assay for Rid activity was adapted from a previously described assay and has been used to assess activity of Rid proteins from several organisms ([@B25]; [@B44]; [@B28]; [@B8]). The 2-iminobutyrate intermediate from 2-aminobutyrate was derivatized with semicarbazide resulting in semicarbazone detected by absorbance at 248 nm. The assay mixture (100 μL total volume) contained potassium pyrophosphate (50 mM, pH 8.7), neutralized semicarbazide (10 mM), bovine liver catalase (1 μg), L-amino acid oxidase (0.5 μg) and 0.1, 1.0 or 10 μM Rid protein. Reactions were started in a 96-well quartz plate with the addition of 2-aminobutyrate to the final concentration of 0.5 mM. Following the addition of substrate, the path length for each well was measured and used along with the molar extinction coefficient for semicarbazone (ε = 10,300 M^--1^ cm^--1^) to calculate the rate of semicarbazone formation. Standard deviation of the mean was determined from three technical triplicates by GraphPad Prism 7.0c.

Motility {#S4.SS6}
--------

Assays for swimming motility were done by modifying previously described methods ([@B23]; [@B46]; [@B43]; [@B59]). Briefly, bacteria were harvested from overnight growth on BHI or MH agar plates into PBS and the OD~600~ was adjusted to 1.0. Ten microliter of the bacteria suspension was inoculated on individual plates by gently piercing the soft agar before expelling the cell suspension into 0.4% agar Brucella, BHI, or MH. Agar plates were incubated at 37°C for 24--72 h. The diameter of each swimming halo was measured and recorded in millimeter (mm). A non-motile *pseC* mutant served as a negative control; the spread of the *pseC* inoculum was subtracted from the motility zone diameter of the experimental strains and the number divided by 2 to get the motility distances as reported in mm. The data shown represent the mean of three technical replicates. For each mutation of interest, three independently isolated mutants were tested to ensure phase variability did not contribute to motility defects. Error bars represent the standard error of the mean. Statistical significance (*P* \< *0.02*) was determined by unpaired Student's test (t test) using GraphPad Prism 7.0c.

Phage NCTC 12673 Plaque Assay {#S4.SS7}
-----------------------------

Plaque formation by NCTC 12673 phage was tested by spotting dilutions of a lysate onto a freshly inoculated bacterial suspension using a standard agar overlay method ([@B31]). Briefly, 100 μL of a bacterial suspension (OD~600~ of ∼0.35) was mixed with 5 mL sterile 0.6% molten NZCYM agar (Sigma-Aldrich, St. Louis, MO) and poured onto the surface of a NZCYM plate. After 15 min, 10 μL aliquots of serial dilutions of a phage lysate were spotted onto the agar surface and allowed to completely dry before incubation at 37°C under microaerobic conditions. After 24 h, plaques were counted and the apparent number of PFU/mL was determined.

Autoagglutination Assays {#S4.SS8}
------------------------

Published protocols for autoagglutination were adapted for use ([@B41]; [@B24]; [@B49]). Simply, cells were harvested from overnight growth on MH agar plates and resuspended in MH broth. The OD~600~ was measured and adjusted to 1.0 in 5 mL of MH broth with 0.002% Tween-20 in a glass test tube. The top 1 mL was removed and OD~600~ measured (OD~600i~). The remaining 4 mL sat without shaking at room temperature in air. At 24, and 48 h, a 1 mL aliquot of the liquid was removed and the absorbance was measured to obtain the recorded OD~600~ (OD~600r~). The percent of autoagglutination (%AAG) reported was calculated as \[(OD~600i~−OD~600r~)/OD~600i~\] × 100.
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